More News

11 Jul 2017 Sanofi to acquire Protein Sciences
08 Jul 2017 Oncology Venture and Eisai Forge Exclusive Global License Agreement for Clinical Stage Oncology Drug PARP Inhibitor E7449 / 2X-121
07 Jul 2017 Entasis Therapeutics and the Global Antibiotic Research & Development Partnership (GARDP) to Develop a New Treatment for Drug-Resistant Gonorrhea
06 Jul 2017 Evotec Received Funding from IFB Hamburg to Identify Antibody-Mediated T-cell Immunotherapies
06 Jul 2017 Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration with BeiGene to Advance PD-1 Inhibitor Program for Solid Tumor Cancers
06 Jul 2017 Trillium Provides Update on Small Molecule Programs
05 Jul 2017 Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform
04 Jul 2017 Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab
30 Jun 2017 Servier and Transgene Have Become Partners to Apply Viral Vectorization Technology to the Engineering of Allogenic CAR-T
27 Jun 2017 NantCell, a NantWorks Company, to Acquire Altor BioScience
27 Jun 2017 Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue
26 Jun 2017 Takeda and Biological E. Limited Announce Partnership to Develop Low-Cost Combination Vaccines for Low- and Middle-Income Countries around the Globe
26 Jun 2017 Alma Bio Therapeutics and Delphi Genetics extend strategic alliance on plasmid DNA drugs
22 Jun 2017 Angion Biomedica Exclusively In-licenses Aldosterone Synthase Inhibitors from ElexoPharm GmbH Complementing its Ongoing Program in Chronic Kidney Disease
21 Jun 2017 Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of Duchenne Muscular Dystrophy
21 Jun 2017 Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Strategic Alliance Agreement
21 Jun 2017 Glenmark Pharmaceuticals Licenses Small Molecule Oncology Compound from APC Therapeutics to Expand Immuno-Oncology Portfolio
21 Jun 2017 Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor
21 Jun 2017 Merck Ventures Creates New Immuno-Oncology Company iOnctura
20 Jun 2017 WILEX AG: Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates
15 Jun 2017 BioTime’s Renevia® Achieves Primary Endpoint in European Pivotal Trial
14 Jun 2017 Domainex expands partnership with Imperial College London to reduce heart muscle damage during heart attacks
13 Jun 2017 Pulmatrix Licenses Novel Drug Candidates from RespiVert Ltd., a wholly owned subsidiary of Janssen Biotech, Inc.
13 Jun 2017 AbbVie and Principia Announce Collaboration on Oral Immunoproteasome Inhibitors
13 Jun 2017 Numab and Kaken Pharmaceutical Co., Ltd. Enter into a Collaboration and Option Agreement

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top